Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,026
archived clinical trials in
Epilepsy

Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
1343
mi
from 91732
Kansas City, MO
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
1343
mi
from 91732
Kansas City, MO
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
2382
mi
from 91732
Cherry Hill, NJ
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
2382
mi
from 91732
Cherry Hill, NJ
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
2181
mi
from 91732
Buffalo, NY
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
2181
mi
from 91732
Buffalo, NY
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
2451
mi
from 91732
Mineola, NY
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
2451
mi
from 91732
Mineola, NY
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
2320
mi
from 91732
Syracuse, NY
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
2320
mi
from 91732
Syracuse, NY
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
2194
mi
from 91732
Chapel Hill, NC
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
2194
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
2217
mi
from 91732
Raleigh, NC
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
2217
mi
from 91732
Raleigh, NC
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
2037
mi
from 91732
Akron, OH
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
2037
mi
from 91732
Akron, OH
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
2036
mi
from 91732
Cleveland, OH
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
1965
mi
from 91732
Columbus, OH
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
1965
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
829
mi
from 91732
Portland, OR
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
829
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
2121
mi
from 91732
Pittsburgh, PA
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
1956
mi
from 91732
Morristown, TN
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
1956
mi
from 91732
Morristown, TN
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
1762
mi
from 91732
Nashville, TN
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
1223
mi
from 91732
Dallas, TX
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
1223
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
1195
mi
from 91732
Fort Worth, TX
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
1195
mi
from 91732
Fort Worth, TX
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
1357
mi
from 91732
Houston, TX
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
573
mi
from 91732
Salt Lake City, UT
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
573
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
2208
mi
from 91732
Charlottesville, VA
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
2208
mi
from 91732
Charlottesville, VA
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
2341
mi
from 91732
Norfolk, VA
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
2341
mi
from 91732
Norfolk, VA
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
2269
mi
from 91732
Richmond, VA
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
2269
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated:  1/16/2017
GSK Investigational Site
6113
mi
from 91732
Capital Federal,
Pediatric Epilepsy Study in Subjects 1-24 Months
An Open-Label, Uncontrolled, Long-Term Study to Assess the Safety of LAMICTAL in Pediatric Subjects Previously Enrolled in Protocol LAM20006 and In LAMICTAL-naive Subjects (1-24 Months of Age)
Status: Enrolling
Updated: 1/16/2017
GSK Investigational Site
6113
mi
from 91732
Capital Federal,
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
21
mi
from 91732
Beverly Hills, CA
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
21
mi
from 91732
Beverly Hills, CA
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
25
mi
from 91732
Sherman Oaks, CA
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
25
mi
from 91732
Sherman Oaks, CA
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
64
mi
from 91732
Temecula, CA
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
64
mi
from 91732
Temecula, CA
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
819
mi
from 91732
Denver, CO
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
819
mi
from 91732
Denver, CO
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
2499
mi
from 91732
Cromwell, CT
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
2499
mi
from 91732
Cromwell, CT
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
2486
mi
from 91732
Hamden, CT
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
2486
mi
from 91732
Hamden, CT
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
2499
mi
from 91732
Middletown, CT
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
2499
mi
from 91732
Middletown, CT
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
2321
mi
from 91732
Miami, FL
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
1908
mi
from 91732
Marietta, GA
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
1908
mi
from 91732
Marietta, GA
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
1714
mi
from 91732
Oak Brook, IL
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
1714
mi
from 91732
Oak Brook, IL
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
1530
mi
from 91732
Cedar Rapids, IA
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
1530
mi
from 91732
Cedar Rapids, IA
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
2274
mi
from 91732
Rockville, MD
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
2274
mi
from 91732
Rockville, MD
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
1952
mi
from 91732
Farmington Hills, MI
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
1952
mi
from 91732
Farmington Hills, MI
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
1609
mi
from 91732
Ridgeland, MS
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
1609
mi
from 91732
Ridgeland, MS
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
2386
mi
from 91732
Moorestown, NJ
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
2386
mi
from 91732
Moorestown, NJ
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
654
mi
from 91732
Albuquerque, NM
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
654
mi
from 91732
Albuquerque, NM
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
2041
mi
from 91732
Beachwood, OH
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
2041
mi
from 91732
Beachwood, OH
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
829
mi
from 91732
Portland, OR
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
829
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
2560
mi
from 91732
Lincoln, RI
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
2560
mi
from 91732
Lincoln, RI
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
1211
mi
from 91732
Austin, TX
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
1211
mi
from 91732
Austin, TX
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
1223
mi
from 91732
Dallas, TX
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
1223
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
1357
mi
from 91732
Houston, TX
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
1367
mi
from 91732
Lake Jackson, TX
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
1367
mi
from 91732
Lake Jackson, TX
Click here to add this to my saved trials
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated:  1/18/2017
GSK Investigational Site
1184
mi
from 91732
San Antonio, TX
Lethargic Depression Study
An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms
Status: Enrolling
Updated: 1/18/2017
GSK Investigational Site
1184
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Staccato® Alprazolam and EEG Photoparoxysmal Response
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status: Enrolling
Updated:  1/30/2017
Consultants in Epilepsy and Neurology, PLLC
667
mi
from 91732
Boise, ID
Staccato® Alprazolam and EEG Photoparoxysmal Response
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status: Enrolling
Updated: 1/30/2017
Consultants in Epilepsy and Neurology, PLLC
667
mi
from 91732
Boise, ID
Click here to add this to my saved trials
Staccato® Alprazolam and EEG Photoparoxysmal Response
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status: Enrolling
Updated:  1/30/2017
New York University Epilepsy Center
2351
mi
from 91732
New York, NY
Staccato® Alprazolam and EEG Photoparoxysmal Response
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status: Enrolling
Updated: 1/30/2017
New York University Epilepsy Center
2351
mi
from 91732
New York, NY
Click here to add this to my saved trials
Staccato® Alprazolam and EEG Photoparoxysmal Response
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status: Enrolling
Updated:  1/30/2017
University of Pennsylvania - Penn Epilepsy Center
2375
mi
from 91732
Philadelphia, PA
Staccato® Alprazolam and EEG Photoparoxysmal Response
Assessment of Staccato® Alprazolam on the EEG Photoparoxysmal Response in Patients With Epilepsy
Status: Enrolling
Updated: 1/30/2017
University of Pennsylvania - Penn Epilepsy Center
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated:  7/18/2017
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
Status: Enrolling
Updated: 7/18/2017
University of Alabama at Birmingham
1777
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials